Elastomeric Infusion Pumps Market Size, Share & Industry Analysis, By Product (Continuous Rate and Variable Rate), By Application (Chemotherapy, Pain Management, Iron Chelation Therapy, and Others), By End User (Hospitals & ASCs, Specialty Clinics, Homecare Settings, and Others), and Regional Forecast, 2026-2034

The global elastomeric infusion pumps market is witnessing significant growth, owing to the increasing prevalence of chronic disorders such as cardiovascular disorders, among others, resulting in growing drug delivery procedures, thereby supporting the growth of elastomeric infusion pumps in the market. Elastomeric infusion pumps are devices that deliver continuous drug delivery and on-demand delivery for pain management, antibacterial therapy, and other conditions among the patient population.

• According to 2024 statistics published by the Heart Failure Society of America (HFSA), approximately 6.7 million Americans over the age of 20 are currently living with heart failure, and this number is projected to rise to 8.7 million by 2030.

Elastomeric Infusion Pumps Market Driver

Increasing Prevalence of Chronic Diseases to Drive Market Growth

The increasing prevalence of acute and chronic diseases such as cancer, diabetes, among others, is resulting in the rising number of drug delivery procedures, such as chemotherapy, and others conducted in healthcare settings. This, along with the growing focus of key players to launch innovative elastomeric infusion pumps, is likely to support the growing adoption rate of these products in the market.

• According to the 2023 statistics published by the Health Care Cost Institute, about 1.0 million people in the U.S. receive chemotherapy each year. 

Incidence of Cancer, Key Countries/Region, 2023 (million)

According to the data published by the Centers for Disease Control and Prevention (CDC), it was reported that the incidence of cancer is 1.9 million in the U.S., 0.5 million in the U.K., 0.6 million in Germany, 0.5 million in France, and 0.4 million in Italy.

Elastomeric Infusion Pumps Market Restraint

High Cost Associated with Elastomeric Infusion Pumps to Hinder Market Growth 

There is a growing demand for innovative elastomeric infusion pumps in healthcare settings. However, the increasing cost of elastomeric infusion pumps among healthcare professionals is likely to limit their adoption rate in the market. 

• According to 2025 statistics published by MFI Medical, it was reported that the cost of a B. Braun Easypump ST/LT elastomeric infusion pump ranges from about USD 120-500.

Elastomeric Infusion Pumps Market Opportunity

The rising prevalence of chronic diseases, along with the benefits of treatment at homecare settings, such as personalized care, cost-effectiveness, among others, is resulting in the preference of patients toward homecare settings. This, along with the growing focus of key players toward R&D initiatives to launch technologically advanced products, is expected to support the growth of the market.

• According to 2024 statistics published by News Medical, it was reported that about 47% of people prefer hospital-at-home care as an alternative to inpatient care in the U.S.

Key Insights

The report covers the following key insights:

• Prevalence of Key Disorders, Key Countries/Regions, 2023
• New Product Launches 
• Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
• Technological Advancements in Elastomeric Infusion Pumps 
• Impact of COVID-19 on the Market 

Segmentation

Analysis by Type

By type, the market is divided into continuous rate and variable rate.

The continuous rate segment held a considerable share in 2024. The increasing focus of prominent players toward receiving approval for novel elastomeric infusion pumps is likely to support the segmental growth in the market. 

• In April 2024, Baxter received U.S. FDA approval for its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software, with the aim of strengthening its product portfolio.

Analysis by Application

By application, the market is divided into chemotherapy, pain management, iron chelation therapy, and others.

The chemotherapy segment held a significant share in 2024. The segmental growth is owing to the growing prevalence of cancer, resulting in an increasing number of procedures for chemotherapy, thereby resulting in increasing demand for drug delivery devices such as elastomeric infusion pumps.

• According to 2024 data published by the Australian Institute of Health and Welfare (AIHW), it was estimated that about 169,000 cases will be diagnosed with cancer in Australia.

Analysis by End User

By end user, the market is divided into hospitals & ASCs, specialty clinics, homecare settings, and others.

The hospitals & ASCs segment held a considerable share in 2024. The growth is owing to certain factors such as improved healthcare infrastructure, a growing number of hospitals & ASCs, rising awareness and demand for the treatment of acute and chronic diseases, among others.

• According to the 2024 data published by Definitive Healthcare, it was reported that there are 9,600 active ambulatory surgical centers in the U.S.

Regional Analysis

By region, the market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.

Request for Customization   to gain extensive market insights.

North America held a significant share of the global elastomeric infusion pumps market in 2024. The growth is due to distinct factors, including the increasing prevalence of acute and chronic disorders, a growing number of drug delivery procedures, a developed healthcare infrastructure, growing per capita healthcare expenditure, and increasing focus on R&D activities, among others.

• According to the 2024 statistics published by the Centers for Medicare & Medicaid Services (CMS), it was reported that the per capita healthcare expenditure is USD 14,750 in the U.S.

Additionally, Europe is expected to grow with a considerable CAGR during the forecast period. The increasing prevalence of acute and chronic conditions and drug delivery procedures is resulting in the growing demand for innovative products in the market. This, along with the growing focus of prominent players toward strategic initiatives, including product launches, acquisitions, among others, is further expected to support the growth of the market in the region.

• According to the 2023 data published by Diabetes UK, it was reported that more than 5.8 million people are living with diabetes in the UK.

On the other hand, Asia Pacific is also expected to grow with a considerable CAGR during the forecast period. The growth is due to the rising number of key players operating in the market offering novel elastomeric infusion pumps. 

Key Players Covered

The global elastomeric infusion pumps market is semi-consolidated, with a few players accounting for the largest share of the elastomeric infusion pumps market. 

The report includes the profiles of the following key players:

• Baxter (U.S.)
• B. Braun SE (Germany)
• Promecon GmbH (Germany)
• Progressive Medical, Inc. (U.S.)
• Terumo Corporation (Japan)
• Vygon (France)
• Leventon (Spain)
• Avanos Medical, Inc. (U.S.)

Key Industry Developments

• In January 2025, Progressive Medical, Inc., launched SMARTeZ elastomeric infusion pumps intended for continuous and intermittent antibiotic infusion, chemotherapy infusion, and general infusion therapies with an aim to strengthen its product portfolio globally.
• In November 2024, Avanos Medical, Inc., announced that its ON-Q elastomeric infusion pump passed the qualifying requirements to become eligible for separate payment under the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act. This helped the company to increase its brand presence.